Publicacións (75) Publicacións nas que participase algún/ha investigador/a

2005

  1. Addressing current challenges in haemophilia care: Consensus recommendations of a European Interdisciplinary Working Group

    Haemophilia, Vol. 11, Núm. 5, pp. 433-437

  2. An empirical study of individual differences in digital library interfaces

    WSEAS Transactions on Computers, Vol. 4, Núm. 10, pp. 1449-1458

  3. Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1

    Clinical Infectious Diseases, Vol. 41, Núm. 2, pp. 227-232

  4. Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

    Antiviral Therapy, Vol. 10, Núm. 7, pp. 779-790

  5. Association of CCR5 human haplogroup E with rapid HIV type 1 disease progression

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 2, pp. 111-115

  6. Atazanavir: The advent of a new generation of more convenient protease inhibitors

    HIV Clinical Trials, Vol. 6, Núm. 1, pp. 50-61

  7. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation

    Journal of Infectious Diseases, Vol. 192, Núm. 12, pp. 2142-2146

  8. Care of patients with chronic hepatitis B and HIV co-infection: Recommendations from an HIV-HBV International Panel

    AIDS, Vol. 19, Núm. 3, pp. 221-240

  9. Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 6, pp. 555-559

  10. Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV Center

    HIV Clinical Trials, Vol. 6, Núm. 6, pp. 329-336

  11. Clinical benefit of interventions driven by therapeutic drug monitoring

    HIV Medicine, Vol. 6, Núm. 5, pp. 360-365

  12. Complications in treating chronic hepatitis B in patients with HIV

    Expert Opinion on Pharmacotherapy, Vol. 6, Núm. 16, pp. 2831-2842

  13. Comunidades virtuales, grupos y proyectos de investigación sobre ims learning design. Status quo, factores clave y retos inmediatos.

    Relieve: Revista ELectrónica de Investigación y EValuación Educativa, Vol. 11, Núm. 2

  14. Con el foco en el "para qué"

    Gestión, Vol. 10, Núm. 1, pp. 126-135

  15. Current concepts in the management and treatment of hepatitis C in HIV-infected patients.

    Annals of hepatology : official journal of the Mexican Association of Hepatology, Vol. 4, Núm. 3, pp. 151-160

  16. Differences in the length of Gag proteins among different HIV type 1 subtypes

    AIDS Research and Human Retroviruses, Vol. 21, Núm. 10, pp. 886-893

  17. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy

    Journal of Acquired Immune Deficiency Syndromes, Vol. 38, Núm. 4, pp. 373-381

  18. Dirección por misiones: ¿la misión de la dirección?

    Revista DYNA, Vol. 80, Núm. 2, pp. 48-50

  19. Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy

    Journal of Clinical Virology, Vol. 34, Núm. 4, pp. 295-301

  20. Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis c virus-coinfected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 39, Núm. 4, pp. 401-405